Winslow Capital Management’s Gilead Sciences GILD Stock Holding History

Winslow Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,814,581	Closed	-$386M	–	143
2015 Q4	$386M	Buy	3,814,581 +1,107,669	+41%	+$115M	1.38%	33
2015 Q3	$266M	Sell	2,706,912 -2,609,594	-49%	-$290M	0.97%	47
2015 Q2	$622M	Buy	5,316,506 +677,462	+15%	+$74M	2.07%	13
2015 Q1	$455M	Sell	4,639,044 -2,548,944	-35%	-$259M	1.4%	30
2014 Q4	$678M	Sell	7,187,988 -789,859	-10%	-$81.7M	2.09%	10
2014 Q3	$849M	Buy	7,977,847 +786,374	+11%	+$77M	2.6%	7
2014 Q2	$596M	Sell	7,191,473 -632,778	-8%	-$49.3M	1.82%	16
2014 Q1	$554M	Sell	7,824,251 -1,565,009	-17%	-$123M	1.74%	17
2013 Q4	$705M	Sell	9,389,260 -272,384	-3%	-$19M	2.08%	13
2013 Q3	$607M	Sell	9,661,644 -456,166	-5%	-$27.3M	1.97%	14
2013 Q2	$519M	Buy	+10,117,810	New	+$527M	1.69%	16

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Winslow Capital Management's GILD Position: Q1 2016 in Review

Winslow Capital Management sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 3,814,581 shares — an estimated $386M sold.

Winslow Capital Management first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $849M in Q3 2014. 1,629 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

Winslow Capital Management reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
Winslow Capital Management sold 3,814,581 Gilead Sciences shares in Q1 2016, an estimated $386M.
Winslow Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
Winslow Capital Management's Gilead Sciences position peaked at $849M in Q3 2014.
1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Winslow Capital Management's 13F filing for Q1 2016, filed 10 May 2016.